220 related articles for article (PubMed ID: 15894292)
1. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
Vyas PM; Roychowdhury S; Woster PM; Svensson CK
Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292
[TBL] [Abstract][Full Text] [Related]
2. Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes.
Khan FD; Roychowdhury S; Nemes R; Vyas PM; Woster PM; Svensson CK
Toxicology; 2006 Feb; 218(2-3):90-9. PubMed ID: 16289751
[TBL] [Abstract][Full Text] [Related]
3. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
Reilly TP; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
5. Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells.
Roychowdhury S; Vyas PM; Svensson CK
Drug Metab Dispos; 2007 Apr; 35(4):676-81. PubMed ID: 17220235
[TBL] [Abstract][Full Text] [Related]
6. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
7. Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.
Bhaiya P; Roychowdhury S; Vyas PM; Doll MA; Hein DW; Svensson CK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):158-67. PubMed ID: 16603214
[TBL] [Abstract][Full Text] [Related]
8. Effect of arylhydroxylamine metabolites of sulfamethoxazole and dapsone on stress signal expression in human keratinocytes.
Khan FD; Vyas PM; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2007 Dec; 323(3):771-7. PubMed ID: 17766678
[TBL] [Abstract][Full Text] [Related]
9. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
10. Role of human cyclooxygenase-2 in the bioactivation of dapsone and sulfamethoxazole.
Vyas PM; Roychowdhury S; Svensson CK
Drug Metab Dispos; 2006 Jan; 34(1):16-8. PubMed ID: 16214851
[TBL] [Abstract][Full Text] [Related]
11. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
Vage C; Saab N; Woster PM; Svensson CK
Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450.
Vyas PM; Roychowdhury S; Khan FD; Prisinzano TE; Lamba J; Schuetz EG; Blaisdell J; Goldstein JA; Munson KL; Hines RN; Svensson CK
J Pharmacol Exp Ther; 2006 Oct; 319(1):488-96. PubMed ID: 16857728
[TBL] [Abstract][Full Text] [Related]
13. Detection of haptenated proteins in organotypic human skin explant cultures exposed to dapsone.
Roychowdhury S; Cram AE; Aly A; Svensson CK
Drug Metab Dispos; 2007 Sep; 35(9):1463-5. PubMed ID: 17553916
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.
Vyas PM; Roychowdhury S; Koukouritaki SB; Hines RN; Krueger SK; Williams DE; Nauseef WM; Svensson CK
J Pharmacol Exp Ther; 2006 Oct; 319(1):497-505. PubMed ID: 16857727
[TBL] [Abstract][Full Text] [Related]
15. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
Grossman SJ; Jollow DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat.
Gill HJ; Hough SJ; Naisbitt DJ; Maggs JL; Kitteringham NR; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Aug; 282(2):795-801. PubMed ID: 9262343
[TBL] [Abstract][Full Text] [Related]
17. Role of lipid peroxidation in dapsone-induced hemolytic anemia.
McMillan DC; Jensen CB; Jollow DJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):868-76. PubMed ID: 9864266
[TBL] [Abstract][Full Text] [Related]
18. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
[TBL] [Abstract][Full Text] [Related]
19. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
20. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.
Reilly TP; Lash LH; Doll MA; Hein DW; Woster PM; Svensson CK
J Invest Dermatol; 2000 Jun; 114(6):1164-73. PubMed ID: 10844561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
